Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Depression as a risk factor for impulse control disorders in Parkinson's disease.

Marín-Lahoz J, Sampedro F, Martinez-Horta S, Pagonabarraga J, Kulisevsky J.

Ann Neurol. 2019 Aug 15. doi: 10.1002/ana.25581. [Epub ahead of print]

PMID:
31415102
2.

Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Lenka A, Pagonabarraga J, Pal PK, Bejr-Kasem H, Kulisvesky J.

Neurology. 2019 Aug 6;93(6):259-266. doi: 10.1212/WNL.0000000000007913. Epub 2019 Jul 9. Review.

PMID:
31289146
3.

Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Behav Brain Res. 2019 Oct 17;372:112039. doi: 10.1016/j.bbr.2019.112039. Epub 2019 Jun 13.

PMID:
31202861
4.

A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.

Aracil-Bolaños I, Sampedro F, Marín-Lahoz J, Horta-Barba A, Martínez-Horta S, Botí M, Pérez-Pérez J, Bejr-Kasem H, Pascual-Sedano B, Campolongo A, Izquierdo C, Gironell A, Gómez-Ansón B, Kulisevsky J, Pagonabarraga J.

Hum Brain Mapp. 2019 Aug 1;40(11):3233-3242. doi: 10.1002/hbm.24593. Epub 2019 Apr 1.

PMID:
30938027
5.

Fragile X-associated tremor/ataxia syndrome: Regional decrease of mitochondrial DNA copy number relates to clinical manifestations.

Alvarez-Mora MI, Podlesniy P, Gelpi E, Hukema R, Madrigal I, Pagonabarraga J, Trullas R, Mila M, Rodriguez-Revenga L.

Genes Brain Behav. 2019 Jun;18(5):e12565. doi: 10.1111/gbb.12565. Epub 2019 May 24.

PMID:
30887649
6.

Reduced gray matter volume in cognitively preserved COMT 158Val/Val Parkinson's disease patients and its association with cognitive decline.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Brain Imaging Behav. 2019 Jan 5. doi: 10.1007/s11682-018-0022-y. [Epub ahead of print]

PMID:
30612340
7.

Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease.

Bejr-Kasem H, Pagonabarraga J, Martínez-Horta S, Sampedro F, Marín-Lahoz J, Horta-Barba A, Aracil-Bolaños I, Pérez-Pérez J, Ángeles Botí M, Campolongo A, Izquierdo C, Pascual-Sedano B, Gómez-Ansón B, Kulisevsky J.

Mov Disord. 2019 Jan;34(1):78-86. doi: 10.1002/mds.27557. Epub 2018 Dec 10.

PMID:
30536829
8.

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Neurobiol Dis. 2019 Apr;124:29-35. doi: 10.1016/j.nbd.2018.11.001. Epub 2018 Nov 6.

PMID:
30408592
9.

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification.

Gironell A, Pascual-Sedano B, Aracil I, Marín-Lahoz J, Pagonabarraga J, Kulisevsky J.

Parkinsons Dis. 2018 Sep 30;2018:4327597. doi: 10.1155/2018/4327597. eCollection 2018.

10.

Cortical Thinning Associated with Age and CSF Biomarkers in Early Parkinson's Disease Is Modified by the SNCA rs356181 Polymorphism.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Neurodegener Dis. 2018;18(5-6):233-238. doi: 10.1159/000493103. Epub 2018 Oct 18.

PMID:
30336481
11.

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity.

Marín-Lahoz J, Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Pascual-Sedano B, Pérez-Pérez J, Gironell A, Kulisevsky J.

Front Psychiatry. 2018 Sep 28;9:465. doi: 10.3389/fpsyt.2018.00465. eCollection 2018.

12.

The impact of bilingualism on brain structure and function in Huntington's disease.

Martínez-Horta S, Moreu A, Perez-Perez J, Sampedro F, Horta-Barba A, Pagonabarraga J, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Parkinsonism Relat Disord. 2019 Mar;60:92-97. doi: 10.1016/j.parkreldis.2018.09.017. Epub 2018 Sep 17.

PMID:
30249427
13.

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Front Neurol. 2018 May 30;9:394. doi: 10.3389/fneur.2018.00394. eCollection 2018.

14.

Structural and metabolic brain correlates of apathy in Huntington's disease.

Martínez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Mov Disord. 2018 Jul;33(7):1151-1159. doi: 10.1002/mds.27395. Epub 2018 Apr 20.

PMID:
29676484
15.

Mcleod syndrome is a new cause of axial muscle weakness.

Díaz-Manera J, Sotoca-Fernández J, Alonso-Jiménez A, Marzo ME, Gallardo E, Segovia-Simón S, Siles AM, Illa I, Pagonabarraga J.

Muscle Nerve. 2018 Jan 30. doi: 10.1002/mus.26086. [Epub ahead of print] No abstract available.

PMID:
29381810
16.

Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.

Prange S, Pagonabarraga J, Krack P, Kulisevsky J, Sgambato V, Tremblay L, Thobois S, Broussolle E.

Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362. No abstract available.

PMID:
29329378
17.

[Safinamide from daily clinical practice: first clinical steps].

Pagonabarraga J, Kulisevsky J.

Rev Neurol. 2017 Nov 16;65(10):433-438. Spanish.

18.

Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma.

Gelpi E, Botta-Orfila T, Bodi L, Marti S, Kovacs G, Grau-Rivera O, Lozano M, Sánchez-Valle R, Muñoz E, Valldeoriola F, Pagonabarraga J, Tartaglia GG, Milà M.

Brain. 2017 Aug 1;140(8):e51. doi: 10.1093/brain/awx156. No abstract available.

PMID:
28899011
19.

Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?

Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Sep 5;3:28. doi: 10.1038/s41531-017-0030-4. eCollection 2017. Review.

20.

Apathy in Parkinson's Disease.

Pagonabarraga J, Kulisevsky J.

Int Rev Neurobiol. 2017;133:657-678. doi: 10.1016/bs.irn.2017.05.025. Epub 2017 Jul 10. Review.

PMID:
28802937
21.

Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS).

Fernández-Bobadilla R, Martínez-Horta S, Marín-Lahoz J, Horta-Barba A, Pagonabarraga J, Kulisevsky J.

Parkinsonism Relat Disord. 2017 Oct;43:73-77. doi: 10.1016/j.parkreldis.2017.07.015. Epub 2017 Jul 19.

PMID:
28754233
22.

[Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy].

Martinez-Castrillo JC, Pena-Segura JL, Sanz-Cartagena P, Alonso-Curco X, Arbelo-Gonzalez JM, Arriola-Pereda G, Coll-Bosch MD, Conejero-Casares JA, Garcia-Ribes A, Jauma-Classen S, Pagonabarraga J, Vidal-Valls J, Garcia-Ruiz PJ.

Rev Neurol. 2017 May 16;64(10):459-470. Review. Spanish.

23.

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients.

Spataro N, Roca-Umbert A, Cervera-Carles L, Vallès M, Anglada R, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Kulisevsky J, Casals F, Clarimón J, Bosch E.

Mov Disord. 2017 Jan;32(1):165-169. doi: 10.1002/mds.26845. Epub 2016 Nov 7.

24.

Facial Dystonia with Facial Grimacing and Vertical Gaze Palsy with "Round the Houses" Sign in a 29-Year-Old Woman.

Crespi J, Bråthen G, Quist-Paulsen P, Pagonabarraga J, Roig-Arnall C.

Neuroophthalmology. 2016 Jan 19;40(1):31-34. eCollection 2016 Feb.

25.

Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.

Martinez-Horta S, Sampedro F, Pagonabarraga J, Fernandez-Bobadilla R, Marin-Lahoz J, Riba J, Kulisevsky J.

Brain Imaging Behav. 2017 Oct;11(5):1334-1342. doi: 10.1007/s11682-016-9607-5.

PMID:
27730477
26.

Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].

Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB; Spanish REGISTRY investigators of the European Huntington's Disease Network, Kulisevsky J.

Parkinsonism Relat Disord. 2016 Oct;31:161. doi: 10.1016/j.parkreldis.2016.08.011. Epub 2016 Aug 25. No abstract available.

PMID:
27567724
27.

Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele.

Rodriguez-Revenga L, Pagonabarraga J, Gómez-Anson B, López-Mourelo O, Izquierdo S, Alvarez-Mora MI, Granell E, Madrigal I, Milà M.

Cerebellum. 2016 Oct;15(5):570-7. doi: 10.1007/s12311-016-0783-z.

PMID:
27315125
28.

Social anxiety and autism spectrum traits among adult FMR1 premutation carriers.

López-Mourelo O, Mur E, Madrigal I, Alvarez-Mora MI, Gómez-Ansón B, Pagonabarraga J, Rodriguez-Revenga L, Milà M.

Clin Genet. 2017 Jan;91(1):111-114. doi: 10.1111/cge.12791. Epub 2016 May 26.

PMID:
27102723
29.

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.

Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB; Spanish REGISTRY investigators of the European Huntington's Disease Network, Kulisevsky J.

Parkinsonism Relat Disord. 2016 Apr;25:58-64. doi: 10.1016/j.parkreldis.2016.02.008. Epub 2016 Feb 11. Erratum in: Parkinsonism Relat Disord. 2016 Oct;31:161.

PMID:
26898966
30.

Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.

Ruzafa-Valiente E, Fernández-Bobadilla R, García-Sánchez C, Pagonabarraga J, Martínez-Horta S, Kulisevsky J.

J Neurol Sci. 2016 Feb 15;361:66-71. doi: 10.1016/j.jns.2015.12.018. Epub 2015 Dec 11.

PMID:
26810519
31.

Functional characterization of two novel mutations in TTF-1/NKX2.1 homeodomain in patients with benign hereditary chorea.

Provenzano C, Zamboni M, Veneziano L, Mantuano E, Garavaglia B, Zorzi G, Pagonabarraga J, Giunti P, Civitareale D.

J Neurol Sci. 2016 Jan 15;360:78-83. doi: 10.1016/j.jns.2015.11.050. Epub 2015 Nov 27.

PMID:
26723978
32.

"String Hallucinations": Multimodal Tactile and Visual Hallucinations in Parkinson's Disease.

Pérez-Pérez J, Pagonabarraga J, Fernández-Bobadilla R, Kulisevsky J.

Mov Disord Clin Pract. 2015 Nov 23;3(2):180-183. doi: 10.1002/mdc3.12252. eCollection 2016 Mar-Apr.

33.

Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.

Cervera-Carles L, Pagonabarraga J, Pascual-Sedano B, Pastor P, Campolongo A, Fortea J, Blesa R, Alcolea D, Morenas-Rodríguez E, Sala I, Lleó A, Kulisevsky J, Clarimón J.

Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):175-80. doi: 10.1002/ajmg.b.32390. Epub 2015 Oct 9.

PMID:
26453547
34.

Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.

Pagonabarraga J, Martinez-Horta S, Fernández de Bobadilla R, Pérez J, Ribosa-Nogué R, Marín J, Pascual-Sedano B, García C, Gironell A, Kulisevsky J.

Mov Disord. 2016 Jan;31(1):45-52. doi: 10.1002/mds.26432. Epub 2015 Sep 26. Erratum in: Mov Disord. 2016 Mar;31(3):433.

PMID:
26408291
35.

Gerstmann-Sträussler-Scheinker Disease Presenting with Atypical Parkinsonism, but Typical Magnetic Resonance Imaging Findings of Prion Disease.

Ribosa-Nogué R, Pagonabarraga J, Gomez-Anson B, Granell-Moreno E, Sánchez-Valle R, Kulisevsky J.

Mov Disord Clin Pract. 2015 Sep 6;3(1):93-95. doi: 10.1002/mdc3.12228. eCollection 2016 Jan-Feb. No abstract available.

36.

Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.

Pérez-Pérez J, Pagonabarraga J, Martínez-Horta S, Fernández-Bobadilla R, Sierra S, Pascual-Sedano B, Gironell A, Kulisevsky J.

Drugs Aging. 2015 May;32(5):401-7. doi: 10.1007/s40266-015-0264-y.

PMID:
25941103
37.

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment.

Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P.

Lancet Neurol. 2015 May;14(5):518-31. doi: 10.1016/S1474-4422(15)00019-8. Epub 2015 Apr 12. Review.

PMID:
25895932
38.

Apathy: who cares?

Krack P, Pagonabarraga J, Strafella AP, Kulisevsky J.

Lancet Neurol. 2015 May;14(5):465. doi: 10.1016/S1474-4422(15)00031-9. Epub 2015 Apr 12. No abstract available.

PMID:
25895927
39.

Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.

Gómez-Ansón B, Román E, Fernández de Bobadilla R, Pires-Encuentra P, Díaz-Manera J, Núñez F, Martinez-Horta S, Vives-Gilabert Y, Pagonabarraga J, Kulisevsky J, Cordoba J, Guarner C, Soriano G.

PLoS One. 2015 Mar 20;10(3):e0118930. doi: 10.1371/journal.pone.0118930. eCollection 2015.

40.

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study.

Pagonabarraga J, Piñol G, Cardozo A, Sanz P, Puente V, Otermín P, Legarda I, Delgado T, Serrano C, Balaguer E, Aguirregomozcorta M, Álvarez R, Kulisevsky JJ.

Parkinsons Dis. 2015;2015:131508. doi: 10.1155/2015/131508. Epub 2015 Feb 22.

41.

Rasagiline for the treatment of parkinsonism in Huntington's disease.

Pérez-Pérez J, Martínez-Horta S, Pagonabarraga J, Carceller M, Kulisevsky J.

Parkinsonism Relat Disord. 2015 Mar;21(3):340-2. doi: 10.1016/j.parkreldis.2015.01.002. Epub 2015 Jan 10. No abstract available.

PMID:
25601128
42.

Mendelian genes for Parkinson's disease contribute to the sporadic forms of the disease.

Spataro N, Calafell F, Cervera-Carles L, Casals F, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Kulisevsky J, Lleó A, Navarro A, Clarimón J, Bosch E.

Hum Mol Genet. 2015 Apr 1;24(7):2023-34. doi: 10.1093/hmg/ddu616. Epub 2014 Dec 11.

PMID:
25504046
43.

Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing.

Martínez-Horta S, Riba J, de Bobadilla RF, Pagonabarraga J, Pascual-Sedano B, Antonijoan RM, Romero S, Mañanas MÀ, García-Sanchez C, Kulisevsky J.

J Neurosci. 2014 Apr 23;34(17):5918-26. doi: 10.1523/JNEUROSCI.0251-14.2014.

44.

Transcranial direct current stimulation of the cerebellum in essential tremor: a controlled study.

Gironell A, Martínez-Horta S, Aguilar S, Torres V, Pagonabarraga J, Pascual-Sedano B, Ribosa-Nogué R.

Brain Stimul. 2014 May-Jun;7(3):491-2. doi: 10.1016/j.brs.2014.02.001. Epub 2014 Feb 6. No abstract available.

PMID:
24582371
45.

Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

Pagonabarraga J, Soriano-Mas C, Llebaria G, López-Solà M, Pujol J, Kulisevsky J.

Parkinsonism Relat Disord. 2014 Mar;20(3):290-6. doi: 10.1016/j.parkreldis.2013.11.017. Epub 2013 Dec 10.

PMID:
24373690
46.

[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].

Pagonabarraga J, Kulisevsky J.

Rev Neurol. 2014 Jan 1;58(1):25-34. Review. Spanish.

47.

Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.

Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Pascual-Sedano B, Campolongo A, Kulisevsky J.

Mov Disord. 2013 Sep;28(10):1376-83. doi: 10.1002/mds.25568. Epub 2013 Jul 19.

PMID:
23873810
48.

Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.

Kulisevsky J, Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Campolongo A, García-Sánchez C, Pascual-Sedano B, Ribosa-Nogué R, Villa-Bonomo C.

Parkinsonism Relat Disord. 2013 Sep;19(9):812-7. doi: 10.1016/j.parkreldis.2013.05.007. Epub 2013 Jun 15.

PMID:
23773412
49.

Apathy in Parkinson's disease: more than just executive dysfunction.

Martínez-Horta S, Pagonabarraga J, Fernández de Bobadilla R, García-Sanchez C, Kulisevsky J.

J Int Neuropsychol Soc. 2013 May;19(5):571-82. doi: 10.1017/S1355617713000131. Epub 2013 Feb 21.

PMID:
23425620
50.

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.

Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, García-Sánchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, Gómez-Ansón B.

PLoS One. 2013;8(1):e54980. doi: 10.1371/journal.pone.0054980. Epub 2013 Jan 24.

Supplemental Content

Loading ...
Support Center